Diagnos Inc.
ADK.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -33.73% | -47.76% | -58.97% | -51.44% | -31.97% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -33.73% | -47.76% | -58.97% | -51.44% | -31.97% |
| Cost of Revenue | 19.13% | 208.16% | 11.51% | 16.05% | 9.84% |
| Gross Profit | -23.27% | -313.52% | -25.03% | -33.65% | -15.38% |
| SG&A Expenses | 9.64% | 34.37% | 109.33% | 61.04% | 56.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.92% | 69.89% | 73.61% | 45.54% | 36.52% |
| Operating Income | -14.12% | -77.35% | -81.89% | -52.99% | -40.16% |
| Income Before Tax | -6.50% | -53.64% | -55.33% | -45.57% | -33.73% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.50% | -53.64% | -55.33% | -45.57% | -33.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.50% | -53.64% | -55.33% | -45.57% | -33.73% |
| EBIT | -14.12% | -77.35% | -81.89% | -52.99% | -40.16% |
| EBITDA | -14.48% | -81.61% | -82.93% | -56.56% | -41.55% |
| EPS Basic | 14.29% | -17.91% | -17.50% | -12.20% | -18.18% |
| Normalized Basic EPS | 14.04% | -16.67% | -18.00% | -13.73% | -18.75% |
| EPS Diluted | 14.29% | -17.91% | -17.50% | -12.20% | -18.18% |
| Normalized Diluted EPS | 14.04% | -16.67% | -18.00% | -13.73% | -18.75% |
| Average Basic Shares Outstanding | 24.17% | 30.63% | 32.07% | 28.45% | 13.96% |
| Average Diluted Shares Outstanding | 24.17% | 30.63% | 32.07% | 28.45% | 13.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |